INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION by E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash

Subjects: Get full text

Ticagrelor inhibits the growth of lung adenocarcinoma by downregulating SYK expression and modulating the PI3K/AKT pathway by Yuanhong Song, Suwei He, Lanhui Zeng, Yuanqiao He, Ling Huang

Subjects: “…Ticagrelor…”
Get full text

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor? by Nil Ozyuncu, Hüseyin Göksülük, Turkan Seda Tan, Kerim Esenboga, Yusuf Atmaca, Çetin Erol

Subjects: Get full text

Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy by Yu Wu, Yilun Zhou, Yuesong Pan, Aoming Jin, Xia Meng, Hao Li, Yilong Wang, Yong Jiang, Yongjun Wang

Subjects: “…Ticagrelor…”
Get full text

Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory by I. A. Pozharnov, A. S. Simakov, N. A. Shulga, A. Yu. Savchenko, O. I. Perederyaev, L. S. Synkova, Yu. V. Medvedev, E. N. Fisher

Subjects: Get full text

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW by I. S. Yavelov

Subjects: Get full text

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE by S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin

Subjects: Get full text

Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS study by Tony Haddad, Osama Elkhateeb, Lawrence Title, Ata Quraishi, Wan Cheol Kim, Ali Hillani, Scott Grandy, Stefan S. Heinze, Finn Eichhorn, Hannah Harquail, John Sapp, William Parker, Shamir R. Mehta, Robert F. Storey, Wael Sumaya

Subjects: Get full text

Bioanalytical method development, in-vivo pharmacokinetic evaluation, ex-vivo platelet aggregation inhibition activity of a novel solid dispersion formulation of ticagrelor by Abhishek Srivastava, Abhishek Srivastava, Simrata Bedi, Abhishesh Kumar Mehata, Datta Maroti Pawde, Ketan Vinayakrao Hatware, Mohammad Ahmad Khan, M. S. Muthu, Uma Bhandari

Subjects: “…ticagrelor…”
Get full text

The effect of ticagrelor and clopidogrel on angiographic parameters according to diabetic status in patients with ST elevation myocardial infarction by F. Aydınyılmaz, H. Sunman, E. Algül, A. Ö. Özkaya İbiş, N. B. Özbeyaz, İ. Guliyev, M. Erzurum, T. Çimen, M. Tulmaç

Subjects: “…ticagrelor…”
Get full text

Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change? by O. V. Averkov, V. I. Vechorko

Subjects: Get full text

Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction by Darae Ko, Peter T. Evans, Kueiyu Joshua Lin, Ashvin N. Pande, Alexander Cervone, Su Been Lee, Susan Cheng, Theodore Tsacogianis, Robert J. Glynn, Dae Hyun Kim

Subjects: Get full text

Potential Clinical Use of CytoSorb^® for Ticagrelor and Rivaroxaban Elimination Prior to Emergency Orthopedic Surgery in Trauma Patients by Gabriele Melegari, Fabio Gazzotti, Federica Arturi, Elisabetta Bertellini, Andrea Tognù, Domenico Pietro Santonastaso, Matteo Villani, Francesca Coppi, Fabrizio Fattorini, Fabio Catani, Alberto Barbieri

Subjects: Get full text

The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case by O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova

Subjects: Get full text

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013 by O. V. Averkov

Subjects: Get full text

Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention by Dunya Habeeb Shnain, Ghassan Mohammed Mahmood, Sara Omar Ahmed

Subjects: Get full text

Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients by O. V. Averkov, V. I. Vechorko

Subjects: Get full text

Protective effects of combined eptifibatide and ticagrelor in patients with unstable angina undergoing percutaneous coronary intervention: a single-center experience by Shangsong Shi, Zicheng Ling, Shaohua Gu, Tingbo Jiang, Lin Ling

Subjects: Get full text

SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME by A. D. Erlikh

Subjects: Get full text

Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis by Liyuan Wang, Yingying Zhao, Shijie Zhang, Tao Zhang, Jian Song, Yan Yun, Yi Wu, Zhengjun Wang, Xiaochun Ma

Subjects: Get full text